CD&R (or the "Firm") today announced the appointment of Giovanni Caforio as an Operating Advisor to CD&R funds. The Firm believes his 35-year career in the international biopharmaceutical industry ...
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that the company’s Board of Directors has appointed Giovanni Caforio, M.D. as chairman of the board, effective May 2, ...
It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO Giovanni Caforio will step down. He’ll be replaced by Christopher Boerner, who is currently chief ...
In his final year as CEO at Bristol Myers Squibb, Giovanni Caforio took a slight dip in pay to $19.7 million, down from the $20.1 million he collected in 2022, according to the company’s proxy filing ...
"I look forward to his continued contributions to patients, shareholders and employees as a member of the Board of Directors." NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced a number of leadership changes approved by its board of directors and effective at the close of the annual ...
Giovanni Caforio Let me just say that with cell mods, we have been discussing the progress with this platform for some time, and I think it's really good to be seen now than we have 5 of those agents ...
Bristol Myers Squibb said on Wednesday CEO Giovanni Caforio will step down in November and be succeeded by Chief Commercialization Officer Christopher Boerner. Boerner, who has been CCO since 2018, ...
Bristol Myers Squibb (BMS) is restructuring its leadership team as its CEO Giovanni Caforio announced he will be retiring later this year after 23 years at the company. BMS announced Wednesday that ...
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that Giovanni Caforio, M.D., has been appointed chief operating officer and elected to Bristol-Myers Squibb's Board ...
Bristol-Myers BMY0.95%increase; up pointing triangle Squibb Co. Chief Executive Giovanni Caforio is planning to retire, the company said Wednesday. Chief Commercialization Officer Christopher Boerner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results